AML Video Channel
Explore the latest insights and summaries from experts in AML.
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Highlights in AML, MDS, and ALL
FEATURING
Talha Badar
- 870 views
- December 24, 2024
- 3
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in AML: 7+3 Is No Longer the Standard of Care
FEATURING
Tapan Kadia
- 959 views
- September 11, 2024
- 12
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid Disease
FEATURING
Hugo F. Fernandez
- 210 views
- December 23, 2024
- 1
Insights from 2024 EHA Annual Meeting
AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024
FEATURING
Talha Badar
- 787 views
- July 16, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 552 views
- September 23, 2024
- 2
Indy Hematology Review
Treatment of AML: Managing the Patient When Transplant Is Not an Option
FEATURING
Harry P. Erba
- 947 views
- April 17, 2024
- 7
Insights from 2023 ASH Annual Meeting
AML and MDS Highlights & Key Takeaways
FEATURING
Talha Badar
- 2,233 views
- January 24, 2024
- 14
Roswell Park Comprehensive Cancer Center
Steroid-Refractory GVHD Updates
FEATURING
Shernan Holtan
- 145 views
- January 24, 2025
Weill Cornell Medicine Oncology & Hematology
Secondary AML: Best Therapy Options
FEATURING
Pinkal Desai
- 128 views
- November 21, 2024
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Emerging Treatment Options for AML in 2024
FEATURING
Alexander Perl
- 737 views
- March 3, 2024
- 4
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of AML in Older Patients
FEATURING
Farhad Ravandi
- 215 views
- August 29, 2024
Total Health
Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL, MM, and CLL
FEATURING
Marcello Maria Rotta
- 308 views
- July 8, 2024
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Immunotherapies in Acute Leukemias: 2024 Update
FEATURING
Catherine Lai
- 548 views
- March 11, 2024
- 3
Insights from 2023 ASH Annual Meeting
Treatment Strategies for Hematocrit Control in PV
FEATURING
Amy Zhou
- 952 views
- January 8, 2024
- 6
UChicago Medicine
Current Management of Accelerated/Blast-Phase MPNs
FEATURING
Anand Patel
- 80 views
- October 25, 2024
- 1
Moffitt Cancer Center
Using Transplant in Patients With p53 Mutant MDS or AML
FEATURING
Hany Elmariah
- 370 views
- March 7, 2024
- 5
UChicago Medicine
AML: Current Treatment Landscape and Key Recent Updates
FEATURING
Anand Patel
- 387 views
- March 20, 2024
- 3
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: AML
FEATURING
Farhad Ravandi
- 389 views
- March 25, 2024
- 2
Vanderbilt University Medical Center (VUMC)
Pre-Transplant Management of High-Risk AML
FEATURING
Kateryna Fedorov
- 101 views
- July 18, 2024
- 2
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
The Truth About Current Consensus Statements on Hematopoietic Cell Transplant
FEATURING
Robert Peter Gale
- 538 views
- February 15, 2024
- 2
Memorial Sloan Kettering Cancer Center
Key Updates in AML, MDS, & MF From ASH
FEATURING
Aaron Goldberg
- 316 views
- May 2, 2024
- 4
Talha Badar
Challenges in the Management of TP53-Mutated AML: Potential Strategies to Improve Outcomes
- 457 views
- March 5, 2024
- 3
MyCancerHaven
Hematopoetic Stem Cell Transplant: How I Decide
FEATURING
Ravi Vij,
Sanghee Hong
- 100 views
- August 30, 2024
- 2
5th SOHO Italy Annual Conference
SOHO Italy 2023: How I Treat AML at MD Anderson Cancer Center
FEATURING
Hagop Kantarjian
- 607 views
- November 28, 2023
- 8
Giuseppe Francesco Milone
The Evolving Landscape of cGVHD Treatment Options
- 41 views
- December 27, 2024
ecancer
EHA 2024 Insights: APOLLO Trial Summary - ATRA + ATO vs. Standard ATRA + Chemo in High-Risk APL
FEATURING
Uwe Platzbecker
- 95 views
- July 24, 2024
Cleveland Clinic Taussig Cancer Institute
Updates in APL: Current SoC and Future Directions
FEATURING
Ben Tomlinson
- 43 views
- October 22, 2024
2024 ASCO® Annual Meeting Insights Hub
Understanding New Strategies to Prevent and Manage Chronic GVHD
FEATURING
Betty Hamilton
- 106 views
- June 16, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in AML: 3+7 is the SOC Induction Therapy for AML
FEATURING
Ant Uzay
- 61 views
- August 15, 2024
- 1
Scripps Health
Managing Intensive-Chemotherapy Ineligible Patients With AML
FEATURING
Courtney D. DiNardo
- 171 views
- March 20, 2024
- 2
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
State of the Art: Role of Maintenance Therapy in AML
FEATURING
Zeba Aziz
- 232 views
- February 15, 2024
MyCancerHaven
Updates in Frontline Treatment of Fit Patients With AML
FEATURING
Ravi Vij,
Manuel Espinoza Gutarra
- 106 views
- April 30, 2024
Yale Cancer Center
Summary of Promising Recent Studies in LR-MDS, HR-MDS, and R/R AML
FEATURING
Rory Shallis
- 93 views
- May 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
A 50-Year Personal Perspective on the Treatment of AML
FEATURING
Charles A. Schiffer
- 167 views
- February 21, 2024
City of Hope
Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Targeted Strategies
FEATURING
Idoroenyi Amanam
- 218 views
- March 11, 2024
- 1
Yale Cancer Center
Yale Cancer Center Allogeneic Stem Cell Transplantation Updates
FEATURING
Lohith Bachegowda
- 88 views
- May 21, 2024
MyCancerHaven
Experts Discuss the Role of Stem Cell Transplant in AML
FEATURING
Ravi Vij,
Muzaffar Qazilbash
- 114 views
- April 11, 2024
- 1
UChicago Medicine
Updates in Transplantation and GVHD From Recent Meetings
FEATURING
Mariam Nawas
- 114 views
- March 25, 2024
Moffitt Cancer Center
Optimal Use of Targeted Therapy for the Elderly or Unfit AML Patient
FEATURING
Onyee Chan
- 109 views
- March 5, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Acute Promyelocytic Leukemia: Risk Stratification and New Treatment Modalities
FEATURING
Suar ÇAkı Kılıç
- 90 views
- February 16, 2024
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: AML
FEATURING
Farhad Ravandi
- 124 views
- October 25, 2023
- 1
Penn Medicine Abramson Cancer Center
Latest Advances in Managing AML in Older Adults - Choosing Therapy and Considerations for Transplant
FEATURING
Shannon McCurdy
- 83 views
- January 19, 2024
University of Colorado Division of Hematology
Current Management of APL and AML
FEATURING
Keri Halsema
- 135 views
- October 24, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 DEBATE: Patients With AML and Active Disease Should Be Transplanted
FEATURING
Hugo F. Fernandez
- 111 views
- October 19, 2023
- 4
5th SOHO Italy Annual Conference
SOHO Italy 2023: A New Conditioning Regimen Pre-Allogeneic Stem Cell Transplantation
FEATURING
Jean El-Cheikh
- 88 views
- November 25, 2023
ecancer
ASH 2024 Insights: Survival and Outcomes in Older, Untreated AML Pts With NPM1 Mutations or KMT2A Rearrangements
FEATURING
Ashley Yocum
- 12 views
- January 21, 2025
UNC Lineberger Comprehensive Cancer Center
UNC Updates on Caring for Older Adults With Acute Leukemia in 2023
FEATURING
Daniel Richardson
- 84 views
- October 23, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Non-Intensive Treatment of Elderly/Unfit Pts With AML - Beyond Venetoclax + HMAs
FEATURING
Tapan Kadia
- 44 views
- November 27, 2023
- 1
ecancer
ASH 2023 Insights: "Updates From the Beat AML Master Trial - A Precision Medicine Approach to AML"
FEATURING
Ashley Yocum
- 32 views
- January 19, 2024
5th SOHO Italy Annual Conference
SOHO Italy 2023: New Insights in AML
FEATURING
Mauricette Michallet
- 39 views
- November 30, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: New Strategies in Induction of Transplant-Eligible AML
FEATURING
Giovanni Marconi
- 20 views
- November 25, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 DEBATE: Prior Therapy Not Needed for Transplanting Patients With R/R AML
FEATURING
Johannes Schetelig
- 21 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Impact of Consolidation Chemo Intensity Before Allogeneic HSCT in Elderly Patients With AML
FEATURING
Yosr Hicheri
- 18 views
- October 19, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Current Role of Allogenic Stem Cell Transplantation and Maintenance in AML
FEATURING
Attilio Olivieri
- 13 views
- November 30, 2023
Therapeutic Agents
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Menin Inhibitors in AML - FDA Approval and Highlights From ASH
FEATURING
Joshua Zeidner
- 339 views
- December 30, 2024
- 4
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Venetoclax + Aza for 1L Younger AML Pts Independent of Fitness for Intensive Therapy
FEATURING
Justin Watts
- 298 views
- December 16, 2024
- 5
Yale Cancer Center
Myeloid Malignancies: Hot Topics in 2024
FEATURING
Nikolai Podoltsev
- 333 views
- October 21, 2024
Moffitt Cancer Center
Cellular Therapies for Myeloid Malignancies
FEATURING
David Sallman
- 122 views
- January 28, 2025
- 1
SOHO Brazil 2024
Where I Use Azacitidine and Venetoclax in AML: Present and Future
FEATURING
Jeffrey Lancet
- 510 views
- July 11, 2024
- 4
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Clinical Study of Oral Azacitidine and Venetoclax in Newly Diagnosed and R/R AML
FEATURING
Maria Amaya
- 118 views
- December 13, 2024
- 1
Indy Hematology Review
HSCT in 2024: What Every Hematologist Needs to Know
FEATURING
Richard Childs
- 852 views
- April 18, 2024
- 5
Louisville Hematology Highlights
Advancements in AML Management in 2024
FEATURING
Curtis Lachowiez
- 133 views
- January 28, 2025
- 2
University of Colorado Division of Hematology
2024 Updates in AML
FEATURING
Christine McMahon
- 781 views
- April 16, 2024
- 6
Icahn School of Medicine at Mount Sinai
BPDCN: Current and Future Directions
FEATURING
Naveen Pemmaraju
- 511 views
- May 31, 2024
- 2
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignancies
FEATURING
Ruemu Birhiray
- 953 views
- April 16, 2024
- 5
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Real-World Data From R/R BPDCN Treated With Tagraxofusp
FEATURING
Emanuele Angelucci
- 228 views
- July 23, 2024
- 1
Icahn School of Medicine at Mount Sinai
Integrating Targeted Therapies in AML
FEATURING
Hagop Kantarjian
- 427 views
- May 31, 2024
- 3
Noah Merin
Axatilimab in cGVHD: Mechanism of Action and Comparison With Current Therapeutic Agents
- 121 views
- November 10, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Ziftomenib + Ven/Aza in R/R NPM1mut or KMT2A-r AML - Interim KOMET-007 Results
FEATURING
Amir Fathi
- 72 views
- December 16, 2024
- 1
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: FLAG-IDA + Venetoclax in Newly Diagnosed or R/R AML
FEATURING
Wei-Ying Jen
- 251 views
- June 26, 2024
- 2
Daniel Wolff
The Role of Axatilimab in Targeting CSF1R for Inflammation and Fibrosis in cGVHD – Recently FDA Approved
- 172 views
- September 6, 2024
- 1
Rush University Medical Center
Management of Viral Infections Post-Transplant: CMV, EBV, and HHV-6
FEATURING
Eric Bhaimia
- 349 views
- May 24, 2024
University of Miami Sylvester Comprehensive Cancer Center
Current and Emerging Treatment Approaches for Patients With AML or MDS
FEATURING
Sangeetha Venugopal
- 144 views
- August 26, 2024
Rush University Medical Center
Allo-HSCT Conditioning Regimens: Current Status and Future Directions
FEATURING
Claudio Brunstein
- 275 views
- May 24, 2024
Marina Konopleva
Considering Venetoclax in AML and ALL - Which Patients and Why
- 62 views
- October 23, 2024
- 2
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: FLAG-GO vs. FLAG-IDA in Untreated Core Binding Factor AML
FEATURING
Gautam Borthakur
- 150 views
- July 1, 2024
- 2
Rush University Medical Center
Selection and Sequencing of Chronic GVHD Therapy
FEATURING
Satyajit Kosuri
- 287 views
- May 24, 2024
- 1
SOHO Brazil 2024
The Gold Standard in the Use of FLT3 and IDH Inhibitors in AML
FEATURING
Jeffrey Lancet
- 138 views
- July 11, 2024
Yale Cancer Center
The Role of Hypomethylating Agent Maintenance in AML
FEATURING
Rory Shallis
- 118 views
- July 1, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Targeted Therapies in AML With a Focus on FLT3 Inhibitors
FEATURING
Naval Daver
- 40 views
- October 8, 2024
Indy Hematology Review
Current & Emerging Therapies for AML and MDS
FEATURING
Rami Komrokji
- 192 views
- May 3, 2024
- 1
Scripps Health
FLT3-Mutated AML: Advances in Frontline Treatment
FEATURING
Nicholas Short
- 249 views
- March 19, 2024
Houston Methodist
Current Treatment Landscape in Myeloid Malignancies
FEATURING
Shilpan Shah
- 62 views
- September 11, 2024
Zachariah DeFilipp
Axatilimab in Chronic GVHD: Updates From the AGAVE-201 Study
- 239 views
- March 27, 2024
5th SOHO Italy Annual Conference
A New Innovative Targeted Therapy for Patients With BPDCN
FEATURING
Giovanni Martinelli
- 558 views
- November 27, 2023
- 1
Najla El-Jurdi
CSF1R's Role in Modulating Inflammation & Fibrosis in cGVHD
- 44 views
- October 16, 2024
Robert Zeiser
CSF1R's Role in Modulating Inflammation and Fibrosis in cGVHD
- 61 views
- August 13, 2024
- 1
5th SOHO Italy Annual Conference
Treatment and Management of BPDCN: Clinical Data and Long-Term Outcomes
FEATURING
Giovanni Marconi
- 329 views
- November 27, 2023
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: AML Highlights - Focus on Menin Inhibitors
FEATURING
Joshua Zeidner
- 69 views
- June 26, 2024
MyCancerHaven
Experts Discuss How to Approach Frontline Treatment of Unfit Patients With AML
- 115 views
- May 22, 2024
MyCancerHaven
Experts Discuss the Use of Targeted Therapies in AML
FEATURING
Ravi Vij,
Eunice Wang
- 241 views
- January 23, 2024
- 1
University of Colorado Division of Hematology
Novel Therapies in AML and MDS
FEATURING
Daniel Pollyea
- 526 views
- October 17, 2023
- 2
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: CML, AML, ALL
FEATURING
Mariam Nawas
- 44 views
- September 3, 2024
Insights from 2023 ASH Annual Meeting
Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis
FEATURING
Douglas Tremblay
- 436 views
- December 13, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Triplet Regimens in AML: Beyond Azacitidine + Venetoclax
FEATURING
Courtney D. DiNardo
- 389 views
- October 16, 2023
- 1
5th SOHO Italy Annual Conference
How I Treat BPDCN at MD Anderson Cancer Center
FEATURING
Naveen Pemmaraju
- 284 views
- November 30, 2023
- 1
Jad Othman
Real-World Outcomes With Venetoclax and Azacitidine in AML Patients
- 18 views
- January 15, 2025
Icahn School of Medicine at Mount Sinai
Therapeutic Targeting of RNA Splicing Factor Mutant Leukemias
FEATURING
Omar Abdel-Wahab
- 62 views
- July 2, 2024
Insights from 2023 ASH Annual Meeting
FLT3-ITD Mutated AML: PROs From the QuANTUM-First Trial of Quizartinib vs. Standard Chemo
FEATURING
Esther Oliva
- 153 views
- March 22, 2024
Insights from 2023 ASH Annual Meeting
The Future Paradigm of HMA + Ven or Targeted Agents in AML: Sequencing and Triplet Combinations
FEATURING
Justin Watts
- 180 views
- January 17, 2024
- 5
ecancer
Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients Undergoing MMUD HCT
FEATURING
Monzr Al Malki,
Steven Devine
- 47 views
- July 24, 2024
Brittany Ragon
Targeting cGVHD: Mechanism of Action of Axatilimab Compared to Other Available Agents
- 25 views
- October 14, 2024
Louisville Hematology Highlights
New Directions in CAR-T: Targeting Novel Antigens
FEATURING
Robert Emmons
- 148 views
- February 27, 2024
- 2
University of Illinois Cancer Center
Latest Advancements in Targeted Therapy in AML
FEATURING
Noah Birch
- 13 views
- December 20, 2024
Insights from 2023 ASH Annual Meeting
FLT3-ITD Mutated AML: QuANTUM-First - Safety by Treatment Phase and by Age in ND Patients
FEATURING
Harry P. Erba
- 209 views
- December 22, 2023
Yale Cancer Center
Targeting Apoptosis in Leukemia: Lessons and Challenges
FEATURING
Marina Konopleva
- 111 views
- March 15, 2024
- 1
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Results From a Ph1 Study of the All-Oral Regimen of CC-486 and Venetoclax For R/R AML"
FEATURING
Maria Amaya
- 158 views
- December 14, 2023
Louisville Hematology Highlights
Is a Bigger Induction "Hammer" Necessarily Better in Today's Stem Cell Transplantation?
FEATURING
William Tse
- 116 views
- February 27, 2024
- 1
Jad Othman
[private - duplicate] Real-World Outcomes With Venetoclax & Azacitidine in AML Patients
- 12 views
- January 16, 2025
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is the Future of Menin Inhibitors in AML?
FEATURING
Ghayas Issa
- 176 views
- October 18, 2023
- 1
Insights from 2023 ASH Annual Meeting
FLT3-ITD Mutated AML: Quizartinib, Venetoclax, & Decitabine Triple Combination
FEATURING
Musa Yilmaz
- 142 views
- December 15, 2023
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Final 5-Year Results of Olutasidenib for Mutated IDH1 AML
FEATURING
Jorge Cortés
- 27 views
- June 28, 2024
- 1
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Revumenib Monotherapy in Pts With R/R KMT2Ar Acute Leukemia From the AUGMENT-101 Study"
FEATURING
Ibrahim Aldoss
- 102 views
- December 29, 2023
Icahn School of Medicine at Mount Sinai
Boosting MHC:TCR Interactions in AML
FEATURING
Iannis Aifantis
- 28 views
- July 2, 2024
Insights from 2023 ASH Annual Meeting
Chronic GVHD: Results from Agave-201 - Axatilimab at 3 Different Doses
FEATURING
Daniel Wolff
- 101 views
- December 29, 2023
ecancer
ASH 2023 Insights: "AUGMENT-101 - Revumenib Monotherapy in Pts With R/R KMT2Ar Acute Leukemia"
FEATURING
Ibrahim Aldoss
- 55 views
- January 18, 2024
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Emerging BCL2 Inhibitors
FEATURING
Mary Ann Anderson
- 139 views
- November 21, 2023
Yale Cancer Center
Immune Checkpoint Inhibition and Novel Therapies for Myelodysplastic Syndromes/Neoplasms
FEATURING
Amer Zeidan
- 174 views
- October 23, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Overcoming Resistance to Venetoclax in AML - A Radical Approach
FEATURING
Vittoria Raimondi
- 130 views
- November 30, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Is AML With Monocytic Features a Separate Entity?
FEATURING
Daniel Pollyea
- 138 views
- October 6, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: How I Manage IDH-Mutated AML at MD Anderson Cancer Center
FEATURING
Courtney D. DiNardo
- 74 views
- November 27, 2023
Yale Cancer Center
Splicing Factor Mutations in MDS: Role in Disease Biology and Potential Therapeutic Targeting
FEATURING
Stephanie Halene
- 29 views
- May 15, 2024
University of Colorado Division of Hematology
Venetoclax and Transplant in AML: Oh, the Places You’ll Go!
FEATURING
Jonathan Gutman
- 111 views
- October 17, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Is The Future of AML All Oral Therapy?
FEATURING
Farhad Ravandi
- 77 views
- November 25, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: TP53 in Myeloid Leukemias - Targeting the Guardian of the Genome
FEATURING
Micheal Andreeff
- 49 views
- November 25, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is the Role of Quizartinib in the Current Landscape of Initial AML Therapy?
FEATURING
Harry P. Erba
- 69 views
- October 5, 2023
Elisabetta Xue
Identifying Steroid-Refractory or Steroid-Dependent cGVHD and the Role of Ruxolitinib
- 18 views
- January 30, 2025
5th SOHO Italy Annual Conference
SOHO Italy 2023: NPM1-Mutated AML - From Bench to Bedside
FEATURING
Lorenzo Brunetii
- 47 views
- November 25, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Immune and Cellular Approaches for AML - Current and Future Directions
FEATURING
Naval Daver
- 33 views
- November 30, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: How I Manage Secondary AML
FEATURING
Francesco Lanza
- 27 views
- November 30, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: How I Manage FLT3 Mutated AML - Moving Towards Cure
FEATURING
Giovanni Martinelli
- 23 views
- November 27, 2023
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "PROs From BMT CTN 1703 Study in GVHD Prophylaxis - a QoL Evaluation"
FEATURING
Shernan Holtan
- 27 views
- December 22, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Role of Immune Checkpoint Inhibitors in AML
FEATURING
Amer Zeidan
- 23 views
- November 25, 2023
ecancer
Epitope Editing Enables Targeted Immunotherapy of AML
FEATURING
Gabriele Casirati
- 22 views
- October 23, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Anti-Leukemic Aurora A Activity in NPM1-mut AML Models
FEATURING
Roberta Ranieri
- 15 views
- November 30, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Overcoming HSP90 Inhibitor Resistance in NPM1 Mutated AML
FEATURING
Ilaria Gionfriddo
- 13 views
- November 30, 2023
Diagnostics & Biomarkers
SOHO Brazil 2024
Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde
FEATURING
Jeffrey Lancet
- 582 views
- July 11, 2024
- 2
Vanderbilt University Medical Center (VUMC)
Prevention and Management of Post-SCT Relapse in Acute Leukemias
FEATURING
Andrew Jallouk
- 275 views
- July 18, 2024
- 6
i3 Health
MRD Testing in Leukemias: When Negativity Is a Positive Thing
FEATURING
Noopur S. Raje
- 486 views
- March 15, 2024
- 1
Rush University Medical Center
What is New in AML: Risk Classification, Germline Mutations, and Targeted Therapies
FEATURING
Ehab Atallah
- 288 views
- May 29, 2024
- 2
Rush University Medical Center
Is Post-HSCT Maintenance the SOC for AML?
FEATURING
Mark Levis
- 340 views
- May 29, 2024
- 4
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Practical Approach to MRD Monitoring in AML: Assessing Treatment Efficacy and Relapse Risk
FEATURING
Tapan Kadia
- 110 views
- September 11, 2024
Giuseppe Francesco Milone
Steroid-Refractory GvHD Management: When to Switch From Steroids
- 90 views
- August 1, 2024
Oncology Data Advisor
Navigating Hereditary Hematologic Malignancy Genetics
FEATURING
Sarah Bannon,
Hiam Abdel-Salam
- 31 views
- November 27, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: IDH Mutated AML - Diagnostic and Treatment Paradigm
FEATURING
Teresa Macarulla Mercade
- 56 views
- September 30, 2024
Icahn School of Medicine at Mount Sinai
Navigating aGVHD Treatment: Integrating Recent Updates in Clinical Management
FEATURING
James Ferrara
- 76 views
- May 31, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Pediatric AML: Diagnosis and Risk Stratification
FEATURING
Nihal Karadaş
- 179 views
- February 16, 2024
Louisville Hematology Highlights
AML: Understanding Risk Stratification and Treatment Approach
FEATURING
Curtis Lachowiez
- 3 views
- January 31, 2025
5th SOHO Italy Annual Conference
SOHO Italy 2023: Targeted Diagnosis & Therapy of NPM1-Mutated AML
FEATURING
Brunangelo Falini
- 48 views
- November 25, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is New in the ICC Classification of AML?
FEATURING
Robert Paul Hasserjian
- 40 views
- October 19, 2023
University of Colorado Division of Hematology
Overview of Physical Exams, Labs and Diagnostic Testing for Blood Cancer Patients
FEATURING
Meredith Beaton
- 30 views
- October 24, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: The Role of Molecular MRD Monitoring in AML - NGS Approaches
FEATURING
Konstanze Doehner
- 24 views
- November 30, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: How Do We Reconcile These AML Classifications in Clinical Management and Research?
FEATURING
Andrew Wei
- 26 views
- October 19, 2023
Rush University Medical Center
[duplicate] Is Post-HSCT Maintenance the SOC for AML?
FEATURING
Mark Levis
- May 29, 2024
Disease Overview
Jesse Hirner
BPDCN: A Dermatologist's Perspective on Differential Diagnosis
- 1,674 views
- August 16, 2024
- 10
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
FEATURING
Robert Peter Gale
- 4,238 views
- February 26, 2024
- 20
MyCancerHaven
Experts Discuss the Pathophysiology, Diagnosis, and Treatment of BPDCN
FEATURING
Ravi Vij,
Guru Murthy
- 678 views
- August 30, 2024
- 3
City of Hope
Acute GVHD: Demographics, Diagnosis, Pathophysiology, and Advancements in Treatment With Corticosteroids & JAK Inhibitors
FEATURING
Amandeep Salhotra
- 72 views
- January 22, 2025
- 1
16th International Congress on Myeloproliferative Neoplasms
PV and Its Relationship to Acute Leukemia
FEATURING
Jerry L. Spivak
- 89 views
- November 26, 2024
- 2
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
AML: Diagnosis, Trends, and Approaches
FEATURING
Mary-Beth Percival
- 104 views
- August 14, 2024
5th SOHO Italy Annual Conference
Characterization and Diagnosis of BPDCN
FEATURING
Sara Fraticelli
- 637 views
- November 27, 2023
- 2
Masonic Cancer Center, University of Minnesota
Blood Cancers Basics
FEATURING
Zohar Sachs
- 37 views
- October 7, 2024
Talha Badar
DDX41 Mutated Germline Predisposition Syndrome-Associated Myeloid Neoplasms - What You Need to Know
- 250 views
- December 4, 2023
- 2
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Update on CHIP and CCUS
FEATURING
Lachelle Weeks
- 252 views
- October 18, 2023
- 1
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
How I Manage Febrile Neutropenia in Patients With Cancer
FEATURING
Şiran Keske
- 72 views
- February 21, 2024
- 1
University of Colorado Division of Hematology
Oncological Emergencies in AML
FEATURING
Glen Peterson
- 165 views
- October 24, 2023
- 1
Nebraska Oncology Society
Survivorship After Transplant and CAR-T for Hematologic Malignancies
FEATURING
Nausheen Ahmed
- 112 views
- November 27, 2023
GRACE
Common Toxicities Associated With Allogeneic HSCT
FEATURING
Muhammad Salman Faisal
- 3 views
- January 30, 2025
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is New in the WHO Classification of AML?
FEATURING
Sanam Loghavi
- 61 views
- October 19, 2023
Louisville Hematology Highlights
The Use of Allo-HCT in the Management of AML
FEATURING
Gordon Phillips
- 31 views
- February 26, 2024
5th SOHO Italy Annual Conference
SOHO Italy 2023: The Pathogenesis of Acute Leukemias - Approaches and Molecular Insights
FEATURING
Ilaria Iacobucci
- 40 views
- November 27, 2023
Masonic Cancer Center, University of Minnesota
"Sleeping Beauty" Implicates Drivers of Leukemic Progression in Mice With Trp53R270H Mutation
FEATURING
Daniel Chang
- 43 views
- January 17, 2024
Masonic Cancer Center, University of Minnesota
The Genetic Epidemiology and Early-Life Origins of Childhood Leukemia
FEATURING
Adam de Smith
- 10 views
- October 8, 2024
5th SOHO Italy Annual Conference
SOHO Italy 2023: WHO 2022 Classification of MPNs - Transitioning From the Optical Into the Molecular Era
FEATURING
Hanan Hamed
- 25 views
- November 27, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Familial Predisposition to AML: Prevalence & Implications for Management
FEATURING
Lucy Godley
- 35 views
- October 19, 2023
Case Studies
Masterclasses in Dermatology
Masterclasses from the Wards
FEATURING
Scott Elman
- 327 views
- March 6, 2024
- 2
Indy Hematology Review
R/R AML: Current, Emerging, and Targeted Therapies
FEATURING
Rami Komrokji
- 358 views
- April 22, 2024
- 3
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of R/R AML: Treatment Options and Case Insights
FEATURING
Valentina Bonuomo
- 44 views
- September 11, 2024
Vanderbilt University Medical Center (VUMC)
Age Limits in Stem Cell Transplants and Cell Therapy
FEATURING
Reena Jayani
- 66 views
- July 22, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
AML Case Discussion: FLT3-ITD+ High-Risk Disease
FEATURING
Fehmi Hindilerden
- 26 views
- September 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Practical Management of AML and MDS in the Elderly
FEATURING
Turgay Ulaş
- 20 views
- October 15, 2024
Tisch Cancer Institute at Mount Sinai
Leukemia Tumor Board: 25 y/o With FLT3-TKD+ AML
FEATURING
Justine Anderson
- 87 views
- May 6, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Case-Based Discussion of MRD in AML
FEATURING
Mehreen Ali Khan
- 22 views
- October 15, 2024
University of Colorado Division of Hematology
Management of Common Emergencies in Blood Cancers
FEATURING
Glen Peterson
- 186 views
- October 24, 2023
Tisch Cancer Institute at Mount Sinai
Tumor Board: Myeloid Sarcoma Manifesting as Small Bowel Obstruction
FEATURING
Justine Anderson
- 27 views
- May 6, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of ATRA-Related Pneumatosis Cystoides Intestinalis in a Patient with APL
FEATURING
Emel Isleyen Kaya
- 6 views
- September 27, 2024
5th SOHO Italy Annual Conference
Case Presentation - Treatment and Management of BPDCN
FEATURING
Marianna Rossi
- 50 views
- November 27, 2023
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Clinical Case of BPDCN
FEATURING
Hanan Hamed
- 25 views
- February 23, 2024